Oral Delivery of GLP-1 and other Incretins: Targeting both Hepatic and Peripheral Uptake to Improve Patient Outcomes
Time: 4:15 pm
day: Conference Day One
Details:
- Hepatic targeting of incretins in metabolic diseases – the importance of mimicking normal physiology
- Highlighting a novel oral delivery platform, hepatic directed vesicles (HDV)
- Reviewing the potential benefits of dual targeting for GLP-1 in both hepatic and peripheral uptake
